- $35.8 million of series 2011 bonds
- $250 million of series 2007A bonds
The outlook remains negative.
The rating affirmation and maintenance of the negative outlook are based on a number of factors, including ETMC’s elevated debt load, weak financial profile and declining market share.
More articles on healthcare finance:
Lee Memorial reports $77M operating income
7 findings on US medical and health R&D spend
5 most-read finance stories: Week of Sept. 19-23
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit